Corporate & Investor Presentation
COPD is a large and growing market
+
More than 380 million people worldwide are estimated to
have COPD 1
- Largely undiagnosed COPD sufferers in high-growth markets.
such as China, India, Brazil and E. Europe may be well over
100 million 1
$ Cost to healthcare systems from COPD is enormous:
· Europe: €48 billion per year²
+
-
-
United States: ~$50 billion per year³
More than 3 million people worldwide die each year
due to COPD4
LET'S TALK ABOUT
The Long-term Health and Economic Burden of
COPD in the United States
A recent study publication (Zafari et al. CHEST 2020) modelled the health and
economic burden of COPD in the US over 20 years from 2019 to 2038
${
Direct medical costs
attributable to COPD
estimated to be
$800.90 billion
$101.30
billion
estimated indirect costs of work
absenteeism
$337.13
billion
$463.77
billion
in men
in women
315.08
million
estimated
number of COPD
exacerbations
1. Adeloye D et al. J Glob Health 2015
2. ERS White Book. https://www.erswhitebook.org/chapters/the-economic-burden-of-lung-disease/
3. NHLBI. Morbidity & Mortality: 2009 Chart Book on Cardiovascular, Lung, and Blood Diseases
4. WHO 2017 https://www.who.int/news-room/fact-sheets/detail/chronic-obstructive-pulmonary-disease-(copd)
17 2021 ResMed | Corporate & Investor Presentation - updated 29APR21
9.42 million estimated COPD deaths
ResMedView entire presentation